Advertisement.

PRRUF Projected Dividend Yield

Immutep Ltd ( OTCBB : PRRUF )

Immutep is a development stage biotech company. Co. is engaged in the development of lymphocyte activation gene 3, or LAG-3, a gene linked to the regulation of T cells in immune responses. Co. focuses on the development of immunotherapeutic products for the treatment of cancer and autoimmune diseases. Co.'s product candidates under development includes: IMP321, a recombinant protein in clinical trials for the treatment of different types of cancers; IMP761, an agonist antibody of LAG-3; IMP701, an antagonist (blocking) antibody targeting the LAG-3 molecule with potential application in the treatment of cancer; and IMP731, a depleting antibody that removes T cells involved in autoimmunity.

20 YEAR PERFORMANCE RESULTS

PRRUF Dividend History Detail
PRRUF Dividend News
PRRUF Competitors News

# of Shares: 0

Closing Price: 0.20

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000